Lilly, Novo Slide as Trump Touts ‘Much Lower’ Ozempic Price

President Donald Trump said the price of the diabetes drug Ozempic will soon be “much lower” and could come down to just $150 a month, pushing shares of Novo Nordisk A/S and Eli Lilly & Co. lower. Sam Fazeli of Bloomberg Intelligence has more.
Do you want to build your own blog website similar to this one? Contact us